Scottsdale Gastroenterology Specialists is working through Reliance Research, an Arizona-based clinical trials site focused on gastroenterology interventional trials. The mission of Reliance Research is to collect essential data to advance gastroenterology care.
The VIVID-1 study is currently enrolling individuals 18 to 80 years of age who have been diagnosed with Crohn’s disease (CD) for at least 3 months. The overall study design includes 28 days for screening, 12 weeks for induction treatment, 40 weeks for maintenance treatment, and up to 16 weeks for the follow-up period. If you think you might be qualified for and interested in this study, please go to the VIVID-1 summary page then contact us to schedule a 15-minute qualifying discussion by phone. Qualified participants will then be scheduled for an in-office appointment to begin the screening process.
We invite you to learn more about clinical trials, the cornerstone of the drug development process. Reliance Research is firmly engaged with the delivery of the best quality data with efficiency and accuracy. The education, experience, and training of our team matched with the right study participants results in the evolution of trusted data.
Reliance Research is led by S. Jaffrey Kazi, MD, one of Arizona’s premier gastroenterologists. In addition to having a busy private practice in Scottsdale, he serves on health system committees, teaches medical students and residents from local hospitals, and is active in clinical research trials for conditions such as celiac disease, Crohn’s disease, GERD, and encephalopathy.
Kartikeya Saxena, MBBS is the Clinical Research Coordinator. A published author, he brings considerable experience as he works directly with patients wishing to be an integral part of the improvement of treatment protocols. Kartikeya’s inherent ability to teach means his focus is on educating trial participants to ensure they are aware of the entire trial process.
To learn more, visit relianceresearch.org or call 480-581-6878.